California Non-AD Diagnostic Reliability Consortium |
Julene Johnson, PhD |
Memory and Aging Center |
|
|
Cognitive Health and Brain Vulnerability in Aging Insulin Resistant Patients |
Victor Valcour, MD, PhD |
Memory and Aging Center |
|
|
Dementia in HIV Patients over 60 Years of Age |
Victor Valcour, MD, PhD |
Memory and Aging Center |
|
|
Central Nervous System Effects in Acute HIV Seroconversion |
Victor Valcour, MD, PhD |
Memory and Aging Center |
|
|
Early Diagnosis of Human Prion Disease |
Michael Geschwind, MD, PhD |
Memory and Aging Center |
|
|
HIV and Global Drug Therapies: Peripheral Neuropathy Complications and Mechanisms |
Victor Valcour, MD, PhD |
Memory and Aging Center |
|
|
HIV-1 Specific Immune Responses in Thai Individuals with HIV Dementia |
Victor Valcour, MD, PhD |
Memory and Aging Center |
|
|
Biomarker Optimization for Progranulin Trials (The BOPT Study) |
Adam Boxer, MD, PhD |
Memory and Aging Center |
|
|
New Approaches to Dementia Heterogeneity |
|
Memory and Aging Center |
|
|
Neurobiological Predictors of Huntington's Disease (Predict-HD) |
Michael Geschwind, MD, PhD |
Memory and Aging Center |
|
|
BMS-241027 on Cerebrospinal Fluid Biomarkers in Subjects with Mild Alzheimer's Disease |
Adam Boxer, MD, PhD |
Memory and Aging Center |
|
|
Peripheral Reservoir of HIV Monocytes Pivotal to Cognition in HIV |
Victor Valcour, MD, PhD |
Memory and Aging Center |
|
|
Neurobiological Changes in Network Function and Amyloid Deposition in Alzheimer Disease |
|
Memory and Aging Center |
|
|
Eye Movement Control in Normal Elderly and MCI |
Adam Boxer, MD, PhD |
Memory and Aging Center |
|
|
Development of Resting-State FMRI As a Biomarker for Alzheimer Disease |
|
Memory and Aging Center |
|
|
National Alzheimer's Coordinating Center, NACC |
|
Memory and Aging Center |
|
|
An Open Label Dose Finding Study of Nimodipine for the Treatment of Frontotemporal Dementia Due to Progranulin Insufficiency From GRN Gene Mutations |
Adam Boxer, MD, PhD |
Memory and Aging Center |
|
|
A Phase I, Randomized, Double-Blind, Placebo-Controlled, Sequential Cohort, Dose-Ranging Study of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of TPI-287 in Patients with Mild to Moderate Alzheimer's Disease |
Adam Boxer, MD, PhD |
Memory and Aging Center |
|
|
The Translational Alzheimer Disease Research Program |
|
Memory and Aging Center |
|
|
Neurodevelopment and Imaging among HIV-infected Children from the PREDICT Study |
Victor Valcour, MD, PhD |
IGHS Faculty Affiliate, Memory and Aging Center |
|
|
Four Repeat Tauopathy Neuroimaging Initiative |
Adam Boxer, MD, PhD |
Memory and Aging Center |
|
|
Samples from Brazilian Aging Brain Study Group |
|
Memory and Aging Center |
|
|
Phase II Study to Evaluate the Efficacy and Safety of MABT5102A in Patients with Mild to Moderate Alzheimer's Diseases |
Adam Boxer, MD, PhD |
Memory and Aging Center |
|
|
The Amyotrophic Lateral Sclerosis (ALS)/Parkinsonism-Dementia Complex of Guam: Exploring the Mechanism of a Rare Tauopathy |
Michael Geschwind, MD, PhD |
Memory and Aging Center |
|
|
Extension of Phase II Studies ABE4869g and ABE4955g in Patients with Mild to Moderate Alzheimer Disease |
Adam Boxer, MD, PhD |
Memory and Aging Center |
|
|
Phase I Multiple Ascending Dose Trial of the MT Stabilizer TPI-287 for Alzheimer Disease (AD) |
Adam Boxer, MD, PhD |
Memory and Aging Center |
|
|
Burden, Depression, and Health in Dementia Caregivers: the Role of Emotion |
|
Memory and Aging Center |
|
|
Frontotemporal Dementia: Genes, Images, and Emotions |
|
Memory and Aging Center |
|
|
Long-Term Central Nervous System (CNS) Consequences of Treatment during Acute Infection |
Victor Valcour, MD, PhD |
IGHS Faculty Affiliate, Memory and Aging Center |
|
|
Mechanisms of Spatial Cognitive Impairment in Neurodegenerative Disease |
|
Memory and Aging Center |
|
|
Midcareer Mentoring Award for Patient-Oriented Research in HIV and Cognition |
Victor Valcour, MD, PhD |
IGHS Faculty Affiliate, Memory and Aging Center |
|
|
Therapeutic Interventions during Acute Infection to Address the CNS Reservoir for HIV |
Victor Valcour, MD, PhD |
IGHS Faculty Affiliate, Memory and Aging Center |
|
|
Predicting Progression of Human Prion Disease |
Michael Geschwind, MD, PhD |
Memory and Aging Center |
|
|
Multi-center evaluation of improved RT-QuIC diagnostic assays for Creutzfeldt-Jakob and other human prion diseases |
Michael Geschwind, MD, PhD |
Memory and Aging Center |
|
|
Determinants of Resilience on Youth with HIV Infection and Youth Affected by HIV |
Victor Valcour, MD, PhD |
IGHS Faculty Affiliate, Memory and Aging Center |
|
|
Causes, treatment and prevention of corticobasal degeneration |
Adam Boxer, MD, PhD |
Memory and Aging Center |
|
|
A Double-Blind, Placebo-Controlled, Randomized, Parallel Group, 12-Month Safety and Efficacy Trial of Leuco-methylthioninium bis(hydromethanesulfonate) in Subjects with Behavioral Variant Frontotemporal Dementia (bvFTD) |
Adam Boxer, MD, PhD |
Memory and Aging Center |
|
|
Developing low-cost cognitive tools for dementia assessment in low-to-middle income countries (LMICs) |
|
Memory and Aging Center |
|
|
Predicting progression of human prion disease |
Michael Geschwind, MD, PhD |
Memory and Aging Center |
|
|
The Frontotemporal Lobar Degeneration Clinical Research Consortium |
Adam Boxer, MD, PhD |
Memory and Aging Center |
|
|
TLC-Pre-gPrd: Tracking Longitudinal Change in Presymptomatic genetic Prion Disease |
Michael Geschwind, MD, PhD |
Memory and Aging Center |
|
|